SCHEMBL24429079

SCHEMBL24429079

CCCCC(C)(C)CN(C)CCC

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.32
GGPS1 O95749 1/20 0.32
FDPS P14324 1/20 0.32
AGTR1 P30556 1/20 0.32
OPRM1 P35372 1/20 0.32
PDE3A Q14432 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19087190 0.84
SCHEMBL20246651 0.82
SCHEMBL18743803 0.82
SCHEMBL17535271 0.82 GGPS1 (0.35) DNM1GGPS1FDPSAGTR1OPRM1
SCHEMBL20032037 0.79 PLA2G1B (0.33)
SCHEMBL14016289 0.78
SCHEMBL24070901 0.78 DNM1 (0.36) DNM1
SCHEMBL18682843 0.75 TSHR (0.32) FDPS
SCHEMBL24927575 0.75
SCHEMBL17535243 0.74 DNM1 (0.33) DNM1GGPS1FDPSAGTR1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3998339-A1 EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY Sarepta Therapeutics, Inc. (US) 2022-05-18 EP disclosed